long half-life and large variability [Regulatives / Guidelines]

posted by dshah – India, 2020-08-10 06:18 (73 d 07:06 ago) – Posting: # 21846
Views: 1,031

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,176 posts in 4,413 threads, 1,475 registered users;
online 8 (0 registered, 8 guests [including 3 identified bots]).
Forum time: Thursday 13:24 CEST (Europe/Vienna)

It is not so much that I have confidence in scientists being right,
but that I have so much in nonscientists being wrong.    Isaac Asimov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5